Skip to main content

Yesterday, Dec. 7, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $47.20 to $44,583,000.00.

Highlighted Stocks Traded by Insiders:

SurModics (SRDX) - FREE Research Report

Stich Joseph J., who is VP, Bus Ops & GM, IVD at SurModics, sold 1,000 shares at $21.18 on Dec. 7, 2015. Following this transaction, the VP, Bus Ops & GM, IVD owned 21,464 shares meaning that the stake was reduced by 4.45% with the 1,000-share transaction.

The shares most recently traded at $21.23, up $0.05, or 0.24% since the insider transaction. Historical insider transactions for SurModics go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 1,500
  • 24-Week # shares sold: 11,000

The average volume for SurModics has been 54,900 shares per day over the past 30 days. SurModics has a market cap of $278.7 million and is part of the health care sector and drugs industry. Shares are down 2.94% year-to-date as of the close of trading on Monday.

SurModics, Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company has a P/E ratio of 23.9. Currently, there are 3 analysts who rate SurModics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SRDX - FREE

TheStreet Quant Ratings

rates SurModics as a

Scroll to Continue

TheStreet Recommends

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full

SurModics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Stage Stores (SSI) - FREE Research Report

Ellis Diane Marie, who is Director at Stage Stores, bought 2,000 shares at $7.65 on Dec. 7, 2015. Following this transaction, the Director owned 20,690 shares meaning that the stake was boosted by 10.7% with the 2,000-share transaction.

The shares most recently traded at $8.20, up $0.55, or 6.71% since the insider transaction. Historical insider transactions for Stage Stores go as follows:

  • 4-Week # shares bought: 58,500
  • 4-Week # shares sold: 4,750
  • 12-Week # shares bought: 58,500
  • 12-Week # shares sold: 4,750
  • 24-Week # shares bought: 58,500
  • 24-Week # shares sold: 4,750

The average volume for Stage Stores has been 961,600 shares per day over the past 30 days. Stage Stores has a market cap of $247.8 million and is part of the services sector and retail industry. Shares are down 62.32% year-to-date as of the close of trading on Monday.

Stage Stores, Inc. operates as a specialty department store retailer in small and mid-sized towns and communities in the United States. Its merchandise portfolio comprises moderately priced brand name and private label apparel, accessories, cosmetics, footwear, and home goods. The stock currently has a dividend yield of 7.75%. The company has a P/E ratio of 7.4. Currently, there is 1 analyst who rates Stage Stores a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SSI - FREE

TheStreet Quant Ratings

rates Stage Stores as a

hold

. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and weak operating cash flow. Get the full

Stage Stores Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Kronos Worldwide (KRO) - FREE Research Report

Watson Steven L, who is Chairman of the Board at Kronos Worldwide, bought 8,200 shares at $5.84 on Dec. 7, 2015. Following this transaction, the Chairman of the Board owned 406,652 shares meaning that the stake was boosted by 2.06% with the 8,200-share transaction.

The shares most recently traded at $5.49, down $0.35, or 6.46% since the insider transaction. Historical insider transactions for Kronos Worldwide go as follows:

  • 4-Week # shares bought: 79,600
  • 12-Week # shares bought: 114,600
  • 24-Week # shares bought: 289,832

The average volume for Kronos Worldwide has been 371,000 shares per day over the past 30 days. Kronos Worldwide has a market cap of $695.3 million and is part of the basic materials sector and chemicals industry. Shares are down 56.45% year-to-date as of the close of trading on Monday.

Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) worldwide. The stock currently has a dividend yield of 10%. The company has a P/E ratio of 1.5. Currently, there are no analysts who rate Kronos Worldwide a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KRO - FREE

TheStreet Quant Ratings

rates Kronos Worldwide as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Kronos Worldwide Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.